Vaxcyte (PCVX) Non-Current Assets (2019 - 2026)
Vaxcyte (PCVX) posted Non-Current Assets of $1.64 billion for Q3 2026, up 16.7% from $1.4 billion a year earlier and up 3.4% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte's Non-Current Assets came in at $1.38 billion, down 20.2% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of 224.5% (FY2020 to FY2025).
- In prior years, Vaxcyte's Non-Current Assets was $1.72 billion in FY2024 (+452.4%), $311.96 million in FY2023 (+390.3%), $63.62 million in FY2022 (-6.4%) and $67.99 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly Non-Current Assets since Q1 2025.
- On a year-over-year basis, Non-Current Assets increased in five of the last eight quarters, with growth averaging 99.6%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2024, with growth of 570.9%; the weakest was Q4 2025, with a decline of 20.2%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $1.59 billion (Q2 2026), $1.53 billion (Q1 2026) and $1.38 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - | 1.64 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.64 Bn |
| Jun 30, 2026 | 1.59 Bn |
| Mar 31, 2026 | 1.53 Bn |
| Dec 31, 2025 | 1.38 Bn |
| Sep 30, 2025 | 1.40 Bn |
| Jun 30, 2025 | 1.59 Bn |
| Mar 31, 2025 | 1.66 Bn |
| Dec 31, 2024 | 1.72 Bn |
| Sep 30, 2024 | 1.35 Bn |
| Jun 30, 2024 | 605.79 Mn |
| Mar 31, 2024 | 574.23 Mn |
| Dec 31, 2023 | 311.96 Mn |
| Sep 30, 2023 | 200.62 Mn |
| Jun 30, 2023 | 192.50 Mn |
| Mar 31, 2023 | 167.49 Mn |
| Dec 31, 2022 | 63.62 Mn |
| Sep 30, 2022 | 42.31 Mn |
| Jun 30, 2022 | 47.89 Mn |
| Mar 31, 2022 | 60.49 Mn |
| Dec 31, 2021 | 67.99 Mn |
API Access
Vaxcyte Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();